Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.
Gauthier J, Castagna L, Garnier F, Guillaume T, Socié G, Maury S, Maillard N, Tabrizi R, Marchand T, Malfuson J, Gac A, Gyan E, Mercier M, Béguin Y, Delage J, Turlure P, Marçais A, Nguyen S, Dulery R, Bay J, Huynh A, Daguindau E, Cornillon J, Régny C, Michallet M, Peffault de Latour R, Yakoub-Agha I, Blaise D. Gauthier J, et al. Among authors: castagna l. Bone Marrow Transplant. 2017 May;52(5):689-696. doi: 10.1038/bmt.2016.349. Epub 2017 Jan 9. Bone Marrow Transplant. 2017. PMID: 28067872
TLI in refractory chronic GVHD.
Devillier R, Castagna L, Gonzague L, El-Cheikh J, Fürst S, Faucher C, Michel R, Blaise D. Devillier R, et al. Among authors: castagna l. Bone Marrow Transplant. 2013 Jun;48(6):854-8. doi: 10.1038/bmt.2012.240. Epub 2012 Dec 10. Bone Marrow Transplant. 2013. PMID: 23222383
Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT.
Castagna L, Boubdallah R, Furst S, Coso D, El Cheikh J, Faucher C, Crocchiolo R, Granata A, Chabannon C, Lemarié C, Calmels B, Boher JM, Mohty M, Blaise D. Castagna L, et al. Bone Marrow Transplant. 2013 Jun;48(6):794-8. doi: 10.1038/bmt.2012.225. Epub 2012 Dec 10. Bone Marrow Transplant. 2013. PMID: 23222387
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors.
Castagna L, Crocchiolo R, Furst S, El-cheikh J, Esterni B, Granata A, Stoppa A, Boubdallah R, Coso D, Vey N, Charbonnier A, Lemarie C, Faucher C, Chabannon C, Blaise D. Castagna L, et al. Bone Marrow Transplant. 2014 Sep;49(9):1246-7. doi: 10.1038/bmt.2014.138. Epub 2014 Jul 7. Bone Marrow Transplant. 2014. PMID: 25000454 No abstract available.
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.
Castagna L, Bramanti S, Furst S, Giordano L, Crocchiolo R, Sarina B, Mauro E, Morabito L, Bouabdallah R, Coso D, Balzarotti M, Broussais F, El-Cheikh J, Stella CC, Brusamolino E, Blaise D, Santoro A. Castagna L, et al. Bone Marrow Transplant. 2014 Dec;49(12):1475-80. doi: 10.1038/bmt.2014.197. Epub 2014 Sep 15. Bone Marrow Transplant. 2014. PMID: 25222502
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available.
Garciaz S, Castagna L, Bouabdallah R, Fürst S, Bramanti S, Coso D, Crocchiolo R, El-Cheikh J, Broussais F, Chabannon C, Santoro A, Blaise D. Garciaz S, et al. Among authors: castagna l. Bone Marrow Transplant. 2015 Jun;50(6):865-7. doi: 10.1038/bmt.2015.22. Epub 2015 Mar 2. Bone Marrow Transplant. 2015. PMID: 25730187 No abstract available.
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.
Devillier R, Bramanti S, Fürst S, Sarina B, El-Cheikh J, Crocchiolo R, Granata A, Chabannon C, Morabito L, Harbi S, Faucher C, Santoro A, Weiller PJ, Vey N, Carlo-Stella C, Castagna L, Blaise D. Devillier R, et al. Among authors: castagna l. Bone Marrow Transplant. 2016 Feb;51(2):194-8. doi: 10.1038/bmt.2015.270. Epub 2015 Nov 9. Bone Marrow Transplant. 2016. PMID: 26551778 Clinical Trial.
Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.
Castagna L, Sarina B, Crocchiolo R, Bramanti S, Furst S, Devillier R, Coso D, Bouabdallah R, Mokart D, Morabito L, Harbi S, Giordano L, Rimondo A, Jean Weiller P, Carlo-Stella C, Santoro A, Chabannon C, Blaise D. Castagna L, et al. Bone Marrow Transplant. 2016 Dec;51(12):1644-1646. doi: 10.1038/bmt.2016.257. Epub 2016 Oct 17. Bone Marrow Transplant. 2016. PMID: 27748737 No abstract available.
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML.
Legrand F, Le Floch AC, Granata A, Fürst S, Faucher C, Lemarie C, Harbi S, Bramanti S, Calmels B, El-Cheikh J, Chabannon C, Weiller PJ, Vey N, Castagna L, Blaise D, Devillier R. Legrand F, et al. Among authors: castagna l. Bone Marrow Transplant. 2017 Apr;52(4):620-621. doi: 10.1038/bmt.2016.326. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941765 No abstract available.
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.
Castagna L, Bramanti S, Devillier R, Sarina B, Crocchiolo R, Furst S, El-Cheikh J, Granata A, Faucher C, Harbi S, Morabito L, Mariotti J, Puvinathan S, Weiller PJ, Chabannon C, Mokart D, Carlo-Stella C, Bouabdallah R, Santoro A, Blaise D. Castagna L, et al. Bone Marrow Transplant. 2017 May;52(5):683-688. doi: 10.1038/bmt.2016.348. Epub 2017 Jan 16. Bone Marrow Transplant. 2017. PMID: 28092347
320 results